These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17328657)

  • 1. Outcomes of a multifaceted medication adherence intervention for HIV-positive patients.
    Dieckhaus KD; Odesina V
    AIDS Patient Care STDS; 2007 Feb; 21(2):81-91. PubMed ID: 17328657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of prior antiretroviral experience on adherence and responses to new highly active antiretroviral therapy regimens.
    Horberg M; Silverberg M; Hurley L; Delorenze G; Quesenberry C
    AIDS Patient Care STDS; 2008 Apr; 22(4):301-12. PubMed ID: 18338961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.
    Wohl AR; Garland WH; Valencia R; Squires K; Witt MD; Kovacs A; Larsen R; Hader S; Anthony MN; Weidle PJ
    Clin Infect Dis; 2006 Jun; 42(11):1619-27. PubMed ID: 16652320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.
    Jevtović D; Dragovic G; Salemović D; Ranin J; Kušić J; Marinković J; Djurković-Djaković O
    Biomed Pharmacother; 2014 Apr; 68(3):391-5. PubMed ID: 24486106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective randomized two-Arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy.
    Tuldrà A; Fumaz CR; Ferrer MJ; Bayés R; Arnó A; Balagué M; Bonjoch A; Jou A; Negredo E; Paredes R; Ruiz L; Romeu J; Sirera G; Tural C; Burger D; Clotet B
    J Acquir Immune Defic Syndr; 2000 Nov; 25(3):221-8. PubMed ID: 11115952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to antiretroviral therapy in HIV-infected pediatric patients improves with home-based intensive nursing intervention.
    Berrien VM; Salazar JC; Reynolds E; McKay K;
    AIDS Patient Care STDS; 2004 Jun; 18(6):355-63. PubMed ID: 15294086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized comparison of two instruments for measuring self-reported antiretroviral adherence.
    Mannheimer S; Thackeray L; Huppler Hullsiek K; Chesney M; Gardner EM; Wu AW; Telzak EE; Lawrence J; Baxter J; Friedland G;
    AIDS Care; 2008 Feb; 20(2):161-9. PubMed ID: 18293124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of short-term success of antiretroviral therapy in HIV infection.
    Oette M; Kroidl A; Göbels K; Stabbert A; Menge M; Sagir A; Kuschak D; O'hanley T; Bode JG; Häussinger D
    J Antimicrob Chemother; 2006 Jul; 58(1):147-53. PubMed ID: 16687458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between adherence level, type of the antiretroviral regimen, and plasma HIV type 1 RNA viral load: a prospective cohort study.
    Martin M; Del Cacho E; Codina C; Tuset M; De Lazzari E; Mallolas J; Miró JM; Gatell JM; Ribas J
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1263-8. PubMed ID: 18834323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
    Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
    Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.
    Nieuwkerk P; Gisolf E; Sprangers M; Danner S;
    Antivir Ther; 2001 Jun; 6(2):97-103. PubMed ID: 11491422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV-infected patients treated in Burkina Faso and Mali.
    Pirkle CM; Boileau C; Nguyen VK; Machouf N; Ag-Aboubacrine S; Niamba PA; Drabo J; Koala S; Tremblay C; Rashed S
    HIV Med; 2009 Mar; 10(3):152-6. PubMed ID: 19245536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of individual cognitive behaviour intervention on adherence to antiretroviral therapy: prospective randomized trial.
    Weber R; Christen L; Christen S; Tschopp S; Znoj H; Schneider C; Schmitt J; Opravil M; Günthard HF; Ledergerber B;
    Antivir Ther; 2004 Feb; 9(1):85-95. PubMed ID: 15040540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-sectional study to evaluate factors associated with adherence to antiretroviral therapy by Brazilian HIV-infected patients.
    Garcia R; Badaró R; Netto EM; Silva M; Amorin FS; Ramos A; Vaida F; Brites C; Schooley RT
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1248-52. PubMed ID: 17209767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.